fbpx

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Neurolens offers the only prescription lenses that use a contoured prism to treat headaches, neck and shoulder pain, and eyestrain caused by eye misalignment. The company recently announced the launch of the N3, a fast and accurate way for eyecare providers to measure eye misalignment down to a fraction of a prism diopter.

“With the introduction of the N3, Neurolens will enable even more eye care professionals to access contoured prism technology in their optometry practices,” said Igor DaCruz, Managing Director, Life Sciences at Trinity. “We are thrilled to work with them as they continue changing the lives of patients.”

This capital will fuel continued growth in the company’s operations and is expected to further accelerate the adoption of Neurolens N3 devices in optometry practices across the United States and Canada.

“While we continue to experience double-digit growth each year, the unmet patient need remains immense,” said Davis Corley, Executive Chairman of Neurolens. “We are committed to leveraging innovative technology like the N3 to remove barriers to adoption and ensure that every eye care professional can access these life-changing outcomes for their patients. We are grateful that Trinity Capital Inc.—along with our dedicated investors—are embracing our mission to transform eye care.”

Click HERE for the full press release.

Featured Posts

Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read More

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read More

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read More

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read More
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more
Optometry Giving Sight logo a turquoise eye with black icons in the shape of people for the iris

Optometry Giving Sight’s Grant Process Begins March 1

Optometry Giving Sight (OGS) will begin accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end preventable blindness and vision impairment throughout the world.

Learn More

CSI Dry Eye Software Announces the Appointment of Trudi Charest as Chief Sales Officer

CSI Dry Eye Software, an emerging AI dry eye software company at the forefront of pioneering artificial intelligence in dry eye diagnostics and treatment recommendations, announces that it has appointed Trudi Charest as CSO – Chief Sales Officer.

Read more

SightGlass Vision Receives Breakthrough Device Designation from U.S. FDA

SightGlass Vision announced that the FDA has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses.

Read more

Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa

A new study from Dr. Eric Pierce and Dr. Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for people with retinitis pigmentosa (RP).

Read more

Custom Lamination Meets Unmatched Style

Featuring a modified round shape with subtly pointed, thoughtfully thickened upper corners, the Fysh F-3725 col. S412 acetate frame radiates sophistication while accentuating the distinctive contours of this eyewear masterpiece.

Read more